HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amide

may prove useful in bispecific antibody pretargeting PET
Also Known As:
DOTA-D-Tyr-D-Lys(HSG)-D-Glu-D-Lys(HSG)-NH2; DOTA-Tyr-Lys(HSG)-Glu-Lys(HSG)-NH2; IMP 288; IMP-288; IMP288
Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Goldenberg, David M: 5 articles (02/2015 - 04/2010)
2. Sharkey, Robert M: 5 articles (02/2015 - 04/2010)
3. Boerman, Otto C: 4 articles (02/2015 - 04/2010)
4. McBride, William J: 4 articles (02/2015 - 04/2010)
5. Oyen, Wim J G: 4 articles (02/2015 - 04/2010)
6. Rossi, Edmund A: 3 articles (08/2014 - 04/2010)
7. van der Graaf, Winette T A: 3 articles (08/2014 - 04/2010)
8. Schoffelen, Rafke: 3 articles (08/2014 - 04/2010)
9. Chang, Chien-Hsing: 2 articles (08/2014 - 04/2010)
10. Eek, Annemarie: 2 articles (11/2010 - 04/2010)

Related Diseases

1. Colorectal Neoplasms (Colorectal Cancer)
2. Neoplasms (Cancer)

Related Drugs and Biologics

1. Investigational Drugs
2. Yttrium
3. Carbon Monoxide
4. procaine isothiocyanate (PRIT)